These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 25447621)

  • 1. Noninvasive tests for the diagnostic evaluation of dyspnea among outpatients: the Multi-Ethnic Study of Atherosclerosis lung study.
    Oelsner EC; Lima JA; Kawut SM; Burkart KM; Enright PL; Ahmed FS; Barr RG
    Am J Med; 2015 Feb; 128(2):171-180.e5. PubMed ID: 25447621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotyping COPD exacerbations using imaging and blood-based biomarkers.
    Alotaibi NM; Chen V; Hollander Z; Hague CJ; Murphy DT; Leipsic JA; DeMarco ML; FitzGerald JM; McManus BM; Ng RT; Sin DD
    Int J Chron Obstruct Pulmon Dis; 2018; 13():217-229. PubMed ID: 29386890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of N-terminal Pro-brain Natriuretic Peptide and Myocardial Perfusion in Asymptomatic Adults (from the Multi-Ethnic Study of Atherosclerosis).
    Mitchell A; Misialek JR; Folsom AR; Duprez D; Alonso A; Jerosch-Herold M; Sanchez OA; Watson KE; Sallam T; Konety SH
    Am J Cardiol; 2015 May; 115(10):1341-5. PubMed ID: 25816778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is N-terminal pro B-type natriuretic peptide (NT-proBNP) a useful screening test for angiographic findings in patients with stable coronary disease?
    Kragelund C; Grønning B; Omland T; Køber L; Strande S; Steffensen R; Hildebrandt P
    Am Heart J; 2006 Mar; 151(3):712.e1-712.e7. PubMed ID: 16504637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients With Stable Angina.
    Caselli C; Prontera C; Liga R; De Graaf MA; Gaemperli O; Lorenzoni V; Ragusa R; Marinelli M; Del Ry S; Rovai D; Giannessi D; Aguade-Bruix S; Clemente A; Bax JJ; Lombardi M; Sicari R; Zamorano J; Scholte AJ; Kaufmann PA; Knuuti J; Underwood SR; Clerico A; Neglia D
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):757-64. PubMed ID: 26868212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlates of dyspnoea and its association with adverse outcomes in a cohort of adults aged 80 and over.
    Hegendörfer E; Vaes B; Matheï C; Van Pottelbergh G; Degryse JM
    Age Ageing; 2017 Nov; 46(6):994-1000. PubMed ID: 28633384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease.
    Tung RH; Camargo CA; Krauser D; Anwaruddin S; Baggish A; Chen A; Januzzi JL
    Ann Emerg Med; 2006 Jul; 48(1):66-74. PubMed ID: 16781921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NT-proBNP in stable COPD and future exacerbation risk: Analysis of the SPIROMICS cohort.
    Labaki WW; Xia M; Murray S; Curtis JL; Barr RG; Bhatt SP; Bleecker ER; Hansel NN; Cooper CB; Dransfield MT; Wells JM; Hoffman EA; Kanner RE; Paine R; Ortega VE; Peters SP; Krishnan JA; Bowler RP; Couper DJ; Woodruff PG; Martinez FJ; Martinez CH; Han MK
    Respir Med; 2018 Jul; 140():87-93. PubMed ID: 29957287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.
    Sirithunyanont C; Leowattana W; Sukumalchantra Y; Chaisupamonkollarp S; Watanawaroon S; Chivatanaporn B; Bhuripanyo K; Mahanonda N
    J Med Assoc Thai; 2003 May; 86 Suppl 1():S87-95. PubMed ID: 12866774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of N-terminal prohormone brain natriuretic peptide assay for etiologic diagnosis of acute dyspnea in elderly patients.
    Berdagué P; Caffin PY; Barazer I; Vergnes C; Sedighian S; Letrillard S; Pilossof R; Goutorbe F; Piot C; Reny JL
    Am Heart J; 2006 Mar; 151(3):690-8. PubMed ID: 16504634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic utility of N-terminal-proBNP in differentiating acute pulmonary embolism from heart failure in patients with acute dyspnea.
    Guo L; Li G; Wang Y; Liang H; Shan X; Zhang N; Wang M; Lin D; Zhu L
    Chin Med J (Engl); 2014; 127(16):2888-93. PubMed ID: 25131222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of renal failure on N-terminal Pro-Brain natriuretic peptide in patients admitted to emergency department with acute dyspnea.
    Çolak A; Çuhadar S; Gölcük B; Gölcük Y; Özdoğan Ö; Çoker I
    Anadolu Kardiyol Derg; 2014 Sep; 14(6):519-24. PubMed ID: 25233498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
    Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL
    J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea.
    Alibay Y; Beauchet A; El Mahmoud R; Schmitt C; Brun-Ney D; Benoit MO; Dubourg O; Boileau C; Jondeau G; Puy H
    Biomed Pharmacother; 2005; 59(1-2):20-4. PubMed ID: 15740931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung ultrasound for the evaluation of pulmonary congestion in outpatients: a comparison with clinical assessment, natriuretic peptides, and echocardiography.
    Miglioranza MH; Gargani L; Sant'Anna RT; Rover MM; Martins VM; Mantovani A; Weber C; Moraes MA; Feldman CJ; Kalil RA; Sicari R; Picano E; Leiria TL
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1141-51. PubMed ID: 24094830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complimentary roles for N-terminal pro-B-type natriuretic peptide and spirometry to assess functional capacity in patients with complex mixed heart valve disease.
    Bissessor N; Wee YS; Jayasinghe R; Zeng I; Lowe B; Kolbe J; Ellyet K; Kerr A; White H; Stewart R
    Kardiol Pol; 2010 Jan; 68(1):1-10. PubMed ID: 20131183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergency thoracic ultrasound in the differentiation of the etiology of shortness of breath (ETUDES): sonographic B-lines and N-terminal pro-brain-type natriuretic peptide in diagnosing congestive heart failure.
    Liteplo AS; Marill KA; Villen T; Miller RM; Murray AF; Croft PE; Capp R; Noble VE
    Acad Emerg Med; 2009 Mar; 16(3):201-10. PubMed ID: 19183402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea.
    Bayes-Genis A; Lloyd-Jones DM; van Kimmenade RR; Lainchbury JG; Richards AM; Ordoñez-Llanos J; Santaló M; Pinto YM; Januzzi JL
    Arch Intern Med; 2007 Feb; 167(4):400-7. PubMed ID: 17325303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
    Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
    J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound lung comets for the differential diagnosis of acute cardiogenic dyspnoea: a comparison with natriuretic peptides.
    Gargani L; Frassi F; Soldati G; Tesorio P; Gheorghiade M; Picano E
    Eur J Heart Fail; 2008 Jan; 10(1):70-7. PubMed ID: 18077210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.